Ally Bridge Group (Ny) LLC Spring Works Therapeutics, Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $88.1 Million
- Q4 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 54,692 shares of SWTX stock, worth $2.71 Million. This represents 2.24% of its overall portfolio holdings.
Number of Shares
54,692
Previous 227,700
75.98%
Holding current value
$2.71 Million
Previous $7.3 Million
72.91%
% of portfolio
2.24%
Previous 5.18%
Shares
2 transactions
Others Institutions Holding SWTX
# of Institutions
236Shares Held
67.2MCall Options Held
260KPut Options Held
316K-
Vanguard Group Inc Valley Forge, PA7.16MShares$355 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$278 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$171 Million5.51% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.27MShares$162 Million0.01% of portfolio
-
State Street Corp Boston, MA3MShares$149 Million0.0% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $3.09B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...